Peptiduria: a potential early predictor of diabetic kidney disease
- 51 Downloads
To protect the kidney effectively with medication in type 2 diabetics, it is crucial to identify such at-risk patients early for treatment. We investigated whether peptiduria precedes proteinuria (the earliest urinary marker in our model), and thereby serve as an early predictor of diabetic nephropathy.
A longitudinal study was performed in a rat model of diabetic nephropathy. Peptides, defined as degradation products of proteins of < 13 kD size, were quantified by a previously validated method using a combination of Lowry and Biorad protein assays. Peptides in urine were also confirmed by chromatographically separating low molecular weight fractions from urine and quantifying albumin fragments in these fractions by enzyme immunoassay. Also, the mechanism of peptiduria was addressed by measuring acid phosphatase, a marker of lysosomal activity, in urine and on kidney sections (histochemically).
In rats with diabetic nephropathy, proteinuria occurred after 12 weeks of diabetes, while peptiduria occurred as early as 2 weeks after diabetes. Peptiduria was confirmed by showing that the chromatographically separated low molecular weight fractions of urine containing albumin fragments is in proportion to the level of peptiduria. The time course of peptiduria paralleled the increase in urinary acid phosphatase suggesting that the mechanism of early peptiduria could be due to upregulation of lysosomal enzyme activity in the tubules.
Our results showing that peptiduria precedes proteinuria in diabetic nephropathy provide a compelling rationale to perform a prospective human clinical trial to investigate whether peptiduria can serve as an early predictor of diabetic nephropathy.
KeywordsProteinuria Diabetic nephropathy Peptiduria Acid phosphatase Histochemistry
The authors wish to acknowledge the technical help of Dr. Lev Rappoport and Ms. Anu Hakimiyan for histological processing of tissues.
I hereby agree that all the authors read the manuscript and agreed with the content.
Financial support for the work was from Hektoen Institute for Medicine, Chicago IL (Grant no. 1994-00107).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interest.
- 5.American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(Suppl 1):511–66.Google Scholar
- 7.Parving HH, Noer I, Deckert T, Evrin PE, Nielsen SL, Lyngose J, Mogensen CE, Rorth M, Svendsen PA, Trap-Jensen J, Lassen NA. The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetes. Diabetologia. 1976;12:161–6.CrossRefGoogle Scholar
- 13.Lowry OH, Rosenbrough NJ, Farr AI, Randall RT. Protein measurement with the Folin-phenol reagent. J Biol Chem. 1951;193:265–75.Google Scholar
- 14.Lodish H, Beck A, Kaiser CA, Krieger M, Scott MP, Bretscher A, Ploegh H, Matsudaira P. Chapter 3. Protein structure and function. In: Lodish H, editor. Molecular cell biology. 6th ed. New York: WH Freeman and Co, 2008, pp. 84–85.Google Scholar
- 15.Koeppen B, Giebisch G, Malic G. Mechansim and regulation of renal tubular acidification. In: Seldin DW, Giebisch G, editors. The kidney: physiology and pathophysiology. New York: Raven Press; 1985. pp. 1491–525.Google Scholar
- 19.Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteom. 2010;9:2424–37.CrossRefGoogle Scholar
- 21.Roscioni SS, de Zeeuw D, Hellemons ME, Mischak H, Zürbig P, Bakker SJL, Gansevoort RT, Reinhard H, Persson F, Lajer F, Rossing M, Lambers P, Heerspink HJ. A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus. Diabetologia. 2013;56:259–67.CrossRefGoogle Scholar